- Activity pressure is positive on the latest completed week.
ABLD
PAR
Week ended 07 Aug 2026
Weekly Investor Report
ABL Diagnostics Société anonyme · Healthcare · Health Information Services
Latest close
2.48 EUR
2.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -16.2% below the Trend Line and sits at 15.1% of its 52-week range. The latest completed week returned 2.5%, after a -1.6% four-week move. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.
Setup score
19
out of 100
Latest Close
2.48 EUR
7 Aug 2026
1W Return
2.5%
latest completed week
4W Return
-1.6%
short-term follow-through
12W Return
-30.8%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 33.63% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.5%
Latest completed week; four-week move -1.6%.
Indicator stack
0/58
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 33.63%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
53/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -16.2% below the Trend Line and sits at 15.1% of its 52-week range. The latest completed week returned 2.5%, after a -1.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1912-week average 0.13
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.19Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -1.6% over four weeks, -30.8% over 12 weeks, and -44.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change101.9%Four-week change in activity pressure.
Leadership-31.49Latest relative-leadership reading.
RS change1.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 3 relevant articles.
1 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-50.4%Distance below the 52-week high.
13-week volatility17.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2617 weeks finished lower.
Best week+55.8%Week of 15 May.
Worst week-18.7%Week of 5 Jun.
Latest week+2.5%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains4
Flat weeks0
Modest losses7
Sharp losses10
Recent vol17.3%13-week weekly-return volatility.
Base vol11.3%52-week weekly-return volatility.
Up/down split20/29Count of positive and negative weeks in the 52-week window.
Average skew7.5% / -6.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank47 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Health Information Services
4-week rank4 / 6
Group average-2.5%
Trend breadth16.7%
Trend16.7%active weekly trend signals
MD50.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape19/100
Trend, activity pressure, participation, and risk combine to a 19/100 tape read.
Indicator analysis19/100Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.19; No reversal markers Next-Week ExpectancyNegative 33.63%Next-week expectancy is negative with a 33.63% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 3 relevant articles.
ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2.48 EUR | 2.5% | 2.96 EUR | 4.76 EUR | 0.00 | -31.49 | 22.4K | Off |
| 31 Jul 2026 | 2.42 EUR | -3.2% | 3.00 EUR | 4.80 EUR | -0.02 | -32.46 | 13.4K | Off |
| 24 Jul 2026 | 2.50 EUR | 6.8% | 3.05 EUR | 4.84 EUR | -0.01 | -30.33 | 82.7K | Off |
| 17 Jul 2026 | 2.34 EUR | -7.1% | 3.07 EUR | 4.88 EUR | -0.16 | -35.66 | 27.3K | Off |
| 10 Jul 2026 | 2.52 EUR | -5.3% | 3.09 EUR | 4.91 EUR | -0.20 | -31.96 | 15.6K | Off |
| 3 Jul 2026 | 2.66 EUR | 13.8% | 3.11 EUR | 4.96 EUR | -0.26 | -30.78 | 5.1K | Off |
| 26 Jun 2026 | 2.34 EUR | -7.6% | 3.13 EUR | 5.00 EUR | -0.34 | -39.27 | 12.1K | Off |
| 19 Jun 2026 | 2.53 EUR | -2.9% | 3.15 EUR | 5.04 EUR | -0.09 | -35.71 | 12.5K | Off |
| 12 Jun 2026 | 2.61 EUR | -2.2% | 3.16 EUR | 5.06 EUR | 0.09 | -34.32 | 45.1K | Off |
| 5 Jun 2026 | 2.66 EUR | -18.7% | 3.17 EUR | 5.09 EUR | 0.33 | -32.85 | 13.3K | Off |
| 29 May 2026 | 3.28 EUR | -2.3% | 3.18 EUR | 5.10 EUR | 0.20 | -18.21 | 147.2K | Off |
| 22 May 2026 | 3.35 EUR | -6.4% | 3.22 EUR | 5.12 EUR | -0.21 | -16.57 | 87.2K | Off |
| 15 May 2026 | 3.58 EUR | 55.8% | 3.26 EUR | 5.13 EUR | -0.54 | -9.99 | 266.3K | Off |
| 8 May 2026 | 2.30 EUR | -0.8% | 3.29 EUR | 5.14 EUR | -0.94 | -43.89 | 23.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.